Back to today’s briefing

Story perspectives

FTC Pauses Legal Battle Against Pharmacy Benefit Managers

4/3/2025

47 6

Summary

Story summary

The Federal Trade Commission (FTC) has hit the brakes on its legal fight against pharmacy benefit managers (PBMs) amid a shortage of commissioners. This pause will last at least 105 days, with a hearing scheduled for 225 days later. The FTC accuses PBMs of driving up insulin prices through unfair practices, while PBMs point fingers at Big Pharma.

1 of 1

Story summary

The Federal Trade Commission (FTC) has hit the brakes on its legal fight against pharmacy benefit managers (PBMs) amid a shortage of commissioners. This pause will last at least 105 days, with a hearing scheduled for 225 days later. The FTC accuses PBMs of driving up insulin prices through unfair practices, while PBMs point fingers at Big Pharma.